Other languages Indivior PLC

Equities

INDV

GB00BN4HT335

Real-time Estimate Cboe Europe Other stock markets 09:49:18 2024-04-30 EDT			5-day change	1st Jan Change
1,458 ^GBX	-0.34%		-4.47%	+22.53%

04-25	Transcript : Indivior PLC, Q1 2024 Earnings Call, Apr 25, 2024
04-25	London-listed Indivior Confirms Plan for Primary Listing in US	MT

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

London-listed Indivior Confirms Plan for Primary Listing in US	04-25
Indivior Seeks Shareholder Nod for Listing in the United States	04-25
UK-listed drugmaker Indivior seeks shareholder nod for US listing	04-25
Indivior shares down despite profit boost on planned shift to New York	04-25
Indivior Reports Higher Q1 Net Income, Net Revenue	04-25
Indivior plc Reconfirms Earnings Guidance for 2024	04-25
Indivior PLC Reports Earnings Results for the First Quarter Ended March 31, 2024	04-25
Addex freine ses pertes et se concentre sur sa nouvelle organisation	04-18
Addex dämmt Verluste ein - Fokus auf neue Struktur	04-18
DELFINGEN Industry : Atos, Nexity, Renault...les valeurs à suivre aujourd'hui à Paris	04-03
Addex externalise sa plateforme technologique dans une nouvelle société	04-03
Bilendi : Argan, Delfingen, Solutions 30...les valeurs à suivre demain à Paris -	04-02
Aelis Farma: trésorerie de 20,2 millions, visibilité jusqu'à fin 2025	04-02
C4X Discovery seeks AIM delisting but half-year revenue skyrockets	03-27
Unilever envisage une cotation de sa division glace à Amsterdam	03-26
Indivior PLC Appoints David E. Wheadon, M.D. as Independent Non-Executive Director, Effective from June 1, 2024	03-21
Indivior CCO Richard Simkin sells GBP1 million in shares	03-18
UBS cuts abrdn price target but ups Darktrace's	03-12
Indivior Says Opvee Shows Drug Reverses Opioid-Induced Respiratory Depression Faster Than Naloxone	03-11
Indivior PLC Announces Publication Demonstrating that OPVEE® Nasal Spray Rapidly Reverses Effects of Opioid-Induced Respiratory Depression in Head-to-Head Study Against Intranasal Naloxone	03-11

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Indivior PLC

Equities

INDV

GB00BN4HT335

Other languages

Filters